Comparison between Advanced Enzyme Technologies IPO and Ujjivan Financial IPO.
Advanced Enzyme Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ujjivan Financial IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Advanced Enzyme Technologies IPO is up to ₹411.49 Cr whereas the issue size of the Ujjivan Financial IPO is up to ₹882.50 Cr. The final issue price of Advanced Enzyme Technologies IPO is ₹896.00 per share and of Ujjivan Financial IPO is ₹210.00 per share.
| Advanced Enzyme Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹880.00 per share | ₹207.00 per share |
| Issue Price (Upper) | ₹896.00 per share | ₹210.00 per share |
| Issue Price (Final) | ₹896.00 per share | ₹210.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹86.00 per share | |
| Market Lot Size | 16 shares | 70 shares |
| Fresh Issue Size | 5,60,405 shares | 1,70,55,277 shares |
| Fresh Issue Size (Amount) | up to ₹50.19 Cr | up to ₹358.16 Cr |
| OFS Issue Size | 40,34,470 shares | 2,49,68,332 shares |
| OFS Issue Size (Amount) | up to ₹361.30 Cr | up to ₹524.33 Cr |
| Issue Size Total | 45,94,875 shares | 4,20,23,609 shares |
| Issue Size Total (Amount) | up to ₹411.49 Cr | up to ₹882.50 Cr |
Advanced Enzyme Technologies IPO opens on Jul 20, 2016, while Ujjivan Financial IPO opens on Apr 28, 2016. The closing date of Advanced Enzyme Technologies IPO and Ujjivan Financial IPO is Jul 22, 2016, and May 02, 2016, respectively.
| Advanced Enzyme Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| Anchor Bid Date | Jul 19, 2016 | Apr 27, 2016 |
| Issue Open | Jul 20, 2016 | Apr 28, 2016 |
| Issue Close | Jul 22, 2016 | May 02, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 01, 2016 | May 10, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Advanced Enzyme Technologies IPO P/E ratio is , as compared to Ujjivan Financial IPO P/E ratio of .
| Advanced Enzyme Technologies IPO | Ujjivan Financial IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.11 | |||||
| Promoter Shareholding (Post-Issue) | 49.52 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2000.41 Cr. | ₹2483.07 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 28.14% | 10.29% |
In the Advanced Enzyme Technologies IPO Retail Individual Investors (RII) are offered 15,99,565 shares while in Ujjivan Financial IPO retail investors are offered 15,99,565 shares. Qualified Institutional Buyers (QIB) are offered 9,14,038 shares in Advanced Enzyme Technologies IPO and 84,04,722 shares in Ujjivan Financial IPO.
| Advanced Enzyme Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,71,053 shares | 1,26,07,081 shares |
| Market Maker Reservation | ||
| QIB | 9,14,038 shares | 84,04,722 shares |
| NII | 6,85,528 shares | 63,03,542 shares |
| RII | 15,99,565 shares | 1,47,08,264 shares |
| Employee | 24,691 shares | |
| Others | ||
| Total | 45,94,875 shares | 4,20,23,609 shares |
Advanced Enzyme Technologies IPO subscribed 116.02x in total, whereas Ujjivan Financial IPO subscribed 40.69x.
| Advanced Enzyme Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| QIB (times) | 94.03x | 33.84x |
| NII (times) | 393.10x | 135.45x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.67x | 4.02x |
| Employee (times) | 1.73x | |
| Other (times) | ||
| Total (times) | 116.02x | 40.69x |
